References

No references inside the corpus for this window.

Cited by

• 1999Inadequate Prescription-Drug Coverage for Medicare Enrollees — A Call to Action168 cited
• 2018Effective healthcare cost-containment policies: A systematic review161 cited
• 2000Transforming Insurance Coverage Into Quality Health Care158 cited
• 2004Benefits And Risks Of Increasing Restrictions On Access To Costly Drugs In Medicaid132 cited
• 2008What impact do prescription drug charges have on efficiency and equity? Evidence from high-income countries128 cited
• 1995Effect of a Prior-Authorization Requirement on the Use of Nonsteroidal Antiinflammatory Drugs by Medicaid Patients124 cited
• 1997The Effect of Increased Prescription Drug Cost-Sharing on Medical Care Utilization and Expenses of Elderly Health Maintenance Organization Members112 cited
• 2002Impact of reference-based pricing for angiotensin-converting enzyme inhibitors on drug utilization.102 cited
• 2009The Effect Of Medicare Part D Coverage On Drug Use And Cost Sharing Among Seniors Without Prior Drug Benefits98 cited
• 2001The Case for a Medicare Drug Coverage Benefit: A Critical Review of the Empirical Evidence84 cited
• 1996The Strategic Response by Pharmaceutical Firms to the Medicaid Most-Favored-Customer Rules75 cited
• 2009Initial effects of a reimbursement restriction to improve the cost-effectiveness of antihypertensive treatment73 cited
• 1997